131 related articles for article (PubMed ID: 38556764)
1. Comment on: Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A case report.
Han JH
Pediatr Blood Cancer; 2024 Jun; 71(6):e30992. PubMed ID: 38556764
[No Abstract] [Full Text] [Related]
2. Use of systemic bivalirudin with catheter-directed thrombolysis in a patient with heparin-induced thrombocytopenia: A case report.
Badreldin HA; Rimsans J; Connors JM; Wiviott SD
Catheter Cardiovasc Interv; 2018 Feb; 91(3):E17-E20. PubMed ID: 29068112
[TBL] [Abstract][Full Text] [Related]
3. Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A case report.
Regling K; Callaghan MU; Rajpurkar M
Pediatr Blood Cancer; 2020 Feb; 67(2):e28094. PubMed ID: 31749252
[TBL] [Abstract][Full Text] [Related]
4. Catheter-directed thrombolysis with alteplase and bivalirudin in a patient with heparin-induced thrombocytopenia.
Martinez LA; Burnett AE
Am J Health Syst Pharm; 2015 May; 72(9):707-10. PubMed ID: 25873618
[TBL] [Abstract][Full Text] [Related]
5. The hemorrhage of information to reduce bleeding complications after percutaneous coronary intervention.
Grines CL; Schreiber T
J Interv Cardiol; 2013 Dec; 26(6):639-40. PubMed ID: 24308661
[No Abstract] [Full Text] [Related]
6. Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.
Runyan CL; Cabral KP; Riker RR; Redding D; May T; Seder DB; Savic M; Hedlund J; Abramson S; Fraser GL
Pharmacotherapy; 2011 Sep; 31(9):850-6. PubMed ID: 21923585
[TBL] [Abstract][Full Text] [Related]
7. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.
Tsu LV; Dager WE
Ann Pharmacother; 2011 Oct; 45(10):1185-92. PubMed ID: 21881032
[TBL] [Abstract][Full Text] [Related]
8. Thrombin inhibitors and cardiopulmonary bypass.
Merry A
J Extra Corpor Technol; 2006 Mar; 38(1):52-6. PubMed ID: 16637526
[No Abstract] [Full Text] [Related]
9. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.
Merry AF; Raudkivi PJ; Middleton NG; McDougall JM; Nand P; Mills BP; Webber BJ; Frampton CM; White HD
Ann Thorac Surg; 2004 Mar; 77(3):925-31; discussion 931. PubMed ID: 14992900
[TBL] [Abstract][Full Text] [Related]
10. Comment on: Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A case report.
Samelson-Jones BJ; Acord MR; Raffini L
Pediatr Blood Cancer; 2020 Dec; 67(12):e28518. PubMed ID: 32618428
[No Abstract] [Full Text] [Related]
11. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
12. Prehospital treatment of patients with acute myocardial infarction with bivalirudin.
Hirschl MM; Mayr H; Erhart F; Brunner W; Steger F; Gattermeier M; Pfeffel F
Am J Emerg Med; 2012 Jan; 30(1):12-7. PubMed ID: 20971597
[TBL] [Abstract][Full Text] [Related]
13. Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database.
Pinto DS; Ogbonnaya A; Sherman SA; Tung P; Normand SL
Circ Cardiovasc Qual Outcomes; 2012 Jan; 5(1):52-61. PubMed ID: 22235065
[TBL] [Abstract][Full Text] [Related]
14. Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study.
Garcia-Garcia HM; Adamo M; Soud M; Yacob O; Picchi A; Sardella G; Frigoli E; Limbruno U; Rigattieri S; Diletti R; Boccuzzi G; Zimarino M; Contarini M; Russo F; Calabrò P; Andò G; Varbella F; Garducci S; Palmieri C; Briguori C; Karagiannis A; Valgimigli M
Catheter Cardiovasc Interv; 2020 Nov; 96(6):1156-1171. PubMed ID: 31883294
[TBL] [Abstract][Full Text] [Related]
15. Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trial.
Venetsanos D; Sederholm Lawesson S; Fröbert O; Omerovic E; Henareh L; Robertsson L; Linder R; Götberg M; James S; Alfredsson J; Erlinge D; Swahn E
Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):502-509. PubMed ID: 30351167
[TBL] [Abstract][Full Text] [Related]
16. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
[TBL] [Abstract][Full Text] [Related]
17. Bivalirudin versus heparin, without glycoprotein inhibition, in percutaneous coronary intervention: A comparison of ischemic and hemorrhagic outcomes over 10years.
Chaudry HI; Curran TB; Andrus BW; Conley SM; DeVries JT
Cardiovasc Revasc Med; 2018; 19(3 Pt B):338-342. PubMed ID: 29055661
[TBL] [Abstract][Full Text] [Related]
18. Bivalirudin versus unfractionated heparin during peripheral vascular interventions: A Propensity-matched Study.
Ortiz D; Singh M; Jahangir A; Allaqaband S; Khitha J; Bajwa TK; Mewissen MW
Catheter Cardiovasc Interv; 2017 Feb; 89(3):408-413. PubMed ID: 27526661
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population.
Shelton R; Eftychiou C; Somers K; Liu A; Burton-Wood N; Anderson M; Makri L; Blaxill J; McLenachan J; Wheatcroft S; Greenwood J; Blackman D
EuroIntervention; 2013 May; 9(1):118-24. PubMed ID: 23410540
[TBL] [Abstract][Full Text] [Related]
20. Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
Verdoia M; Barbieri L; Parodi G; Bellandi B; Schaffer A; Suryapranata H; De Luca G
Catheter Cardiovasc Interv; 2017 Oct; 90(4):553-565. PubMed ID: 28471057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
